NanoenTekInc
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a resid… Read more
NanoenTekInc (039860) - Net Assets
Latest net assets as of September 2025: ₩73.19 Billion KRW
Based on the latest financial reports, NanoenTekInc (039860) has net assets worth ₩73.19 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩78.61 Billion) and total liabilities (₩5.42 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩73.19 Billion |
| % of Total Assets | 93.1% |
| Annual Growth Rate | 7.02% |
| 5-Year Change | 62.67% |
| 10-Year Change | 92.65% |
| Growth Volatility | 23.22 |
NanoenTekInc - Net Assets Trend (2007–2024)
This chart illustrates how NanoenTekInc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NanoenTekInc (2007–2024)
The table below shows the annual net assets of NanoenTekInc from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩73.99 Billion | +38.07% |
| 2023-12-31 | ₩53.59 Billion | -7.04% |
| 2022-12-31 | ₩57.65 Billion | +10.14% |
| 2021-12-31 | ₩52.34 Billion | +15.07% |
| 2020-12-31 | ₩45.49 Billion | +10.87% |
| 2019-12-31 | ₩41.03 Billion | +16.71% |
| 2018-12-31 | ₩35.15 Billion | +48.12% |
| 2017-12-31 | ₩23.73 Billion | -7.22% |
| 2016-12-31 | ₩25.58 Billion | -33.41% |
| 2015-12-31 | ₩38.41 Billion | +8.19% |
| 2014-12-31 | ₩35.50 Billion | +50.57% |
| 2013-12-31 | ₩23.58 Billion | +2.62% |
| 2012-12-31 | ₩22.98 Billion | -20.08% |
| 2011-12-31 | ₩28.75 Billion | +23.11% |
| 2007-12-31 | ₩23.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to NanoenTekInc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2298174459000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩22.98 Billion | 31.06% |
| Common Stock | ₩16.06 Billion | 21.70% |
| Other Components | ₩34.96 Billion | 47.24% |
| Total Equity | ₩73.99 Billion | 100.00% |
NanoenTekInc Competitors by Market Cap
The table below lists competitors of NanoenTekInc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nexen Corporation
KO:005720
|
$79.25 Million |
|
TOLUF
OTCQX:TOLUF
|
$79.29 Million |
|
Daihan Pharmaceutical Co.Ltd
KQ:023910
|
$79.31 Million |
|
FFD Financial Corp
PINK:FFDF
|
$79.32 Million |
|
Dusit Thani Public Company Limited
BK:DUSIT
|
$79.16 Million |
|
Kenilworth Systems C
PINK:KENS
|
$79.13 Million |
|
Alpha Cognition Inc
NASDAQ:ACOG
|
$79.11 Million |
|
Cardiol Therapeutics Inc Class A
NASDAQ:CRDL
|
$79.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NanoenTekInc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 53,592,936,320 to 73,994,475,560, a change of 20,401,539,240 (38.1%).
- Net income of 3,585,804,450 contributed positively to equity growth.
- Share repurchases of 17,498,831,430 reduced equity.
- New share issuances of 17,498,831,430 increased equity.
- Other factors increased equity by 16,815,734,790.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩3.59 Billion | +4.85% |
| Share Repurchases | ₩17.50 Billion | -23.65% |
| Share Issuances | ₩17.50 Billion | +23.65% |
| Other Changes | ₩16.82 Billion | +22.73% |
| Total Change | ₩- | 38.07% |
Book Value vs Market Value Analysis
This analysis compares NanoenTekInc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.88x to 2.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1046.58 | ₩6150.00 | x |
| 2017-12-31 | ₩969.87 | ₩6150.00 | x |
| 2018-12-31 | ₩1336.88 | ₩6150.00 | x |
| 2019-12-31 | ₩1559.21 | ₩6150.00 | x |
| 2020-12-31 | ₩1697.51 | ₩6150.00 | x |
| 2021-12-31 | ₩1952.98 | ₩6150.00 | x |
| 2022-12-31 | ₩2150.46 | ₩6150.00 | x |
| 2023-12-31 | ₩1999.17 | ₩6150.00 | x |
| 2024-12-31 | ₩2304.40 | ₩6150.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NanoenTekInc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.77%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.07x
- Recent ROE (4.85%) is above the historical average (-3.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -6.94% | -12.64% | 0.45x | 1.22x | ₩-6.01 Billion |
| 2015 | -18.96% | -29.32% | 0.47x | 1.37x | ₩-11.12 Billion |
| 2016 | -57.86% | -66.64% | 0.49x | 1.79x | ₩-17.36 Billion |
| 2017 | -8.73% | -8.70% | 0.56x | 1.79x | ₩-4.45 Billion |
| 2018 | 9.41% | 12.82% | 0.61x | 1.20x | ₩-206.81 Million |
| 2019 | 14.02% | 21.90% | 0.56x | 1.14x | ₩1.65 Billion |
| 2020 | 6.02% | 9.29% | 0.56x | 1.16x | ₩-1.81 Billion |
| 2021 | 13.99% | 20.46% | 0.57x | 1.19x | ₩2.09 Billion |
| 2022 | 8.09% | 13.25% | 0.56x | 1.10x | ₩-1.10 Billion |
| 2023 | -6.86% | -13.71% | 0.46x | 1.09x | ₩-9.04 Billion |
| 2024 | 4.85% | 11.77% | 0.39x | 1.07x | ₩-3.81 Billion |
Industry Comparison
This section compares NanoenTekInc's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $91,839,783,547
- Average return on equity (ROE) among peers: 9.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NanoenTekInc (039860) | ₩73.19 Billion | -6.94% | 0.07x | $79.23 Million |
| 068100 (068100) | $8.27 Billion | -29.84% | 0.79x | $9.95 Million |
| THINKWARE Corporation (084730) | $181.09 Billion | 1.85% | 0.92x | $33.86 Million |
| Mobile Appliance Inc. (087260) | $43.74 Billion | 5.72% | 0.85x | $36.80 Million |
| Suprema HQ Inc (094840) | $209.14 Billion | 17.82% | 0.10x | $20.47 Million |
| Woojin (105840) | $116.53 Billion | 2.21% | 0.26x | $202.94 Million |
| HyVision System. Inc (126700) | $200.33 Billion | 12.00% | 0.54x | $128.35 Million |
| DAIHAN Scientific Co. Ltd (131220) | $18.57 Billion | 3.74% | 1.03x | $13.44 Million |
| Parksystems Corp (140860) | $30.56 Billion | 14.87% | 0.21x | $772.61 Million |
| LET co. Ltd (297890) | $18.34 Billion | 56.84% | 1.16x | $64.81 Million |